

Mark Charny
Managing Director, Translucency Ltd.Mark has been Managing Director of Translucency Limited, a reimbursement consultancy based in the UK and with an associate network across Western Europe since 1999. Prior to that he was Director of the English National Centre for Clinical Audit, after three years as Senior Medical Office in the UK Department of Health responsible for clinical effectiveness and clinical guidelines. Earlier in his career he held a senior management position in the NHS, having spent several years as a general practitioner (family physician).
His major areas of expertise include evidence-based product support, including epidemiology, study design, data analysis, and cost-effectiveness analysis. He has published extensively in peer-reviewed journals, spoken widely at conferences, and referees for the UK National Institute of Health Research Health Technology Assessment programme.
Posted on 10.04.2013
Does investing in demonstrating value help with reimbursement for new medical technologies?


By Mark Charny, Managing Director, Translucency Ltd.